Cell‐based and antibody‐mediated immunotherapies directed against leukemic stem cells in acute myeloid leukemia: Perspectives and open issues

Despite new insights in molecular features of leukemic cells and the availability of novel treatment approaches and drugs, acute myeloid leukemia (AML) remains a major clinical challenge. In fact, many patients with AML relapse after standard therapy and eventually die from progressive disease. The...

Descripción completa

Detalles Bibliográficos
Autores principales: Valent, Peter, Bauer, Karin, Sadovnik, Irina, Smiljkovic, Dubravka, Ivanov, Daniel, Herrmann, Harald, Filik, Yüksel, Eisenwort, Gregor, Sperr, Wolfgang R., Rabitsch, Werner
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2020
Materias:
Concise Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7581453/
https://www.ncbi.nlm.nih.gov/pubmed/32657052
http://dx.doi.org/10.1002/sctm.20-0147

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7581453/
https://www.ncbi.nlm.nih.gov/pubmed/32657052
http://dx.doi.org/10.1002/sctm.20-0147

Ejemplares similares